Glucocorticoids—All-Rounders Tackling the Versatile Players of the Immune System

Strehl, Cindy, Ehlers, Lisa, Gaber, Timo, Buttgereit, Frank·2019·Frontiers in Immunology

Cites (281)

Items 201–281 of 281

  1. Increasing Doses of Inhaled Corticosteroids Compared to Adding Long-Acting Inhaled β 2 -Agonists in Achieving Asthma Control
    Paul M. O’Byrne, Ian P. Naya, Anders Källén · 2008 · CHEST Journal
  2. A gradient of glucocorticoid sensitivity among helper T cell cytokines
    J. Banuelos, N. Lu · 2016 · Cytokine & growth factor reviews
  3. INFLUENCE OF ADRENAL CORTICAL SECRETION ON BLOOD ELEMENTS
    Thomas F. Dougherty, A. WHITE · 1943 · Science
  4. Glucocorticoid-mediated BIM induction and apoptosis are regulated by Runx2 and c-Jun in leukemia cells
    N. Heidari, Anna V. Miller, M A Hicks · 2012 · Cell Death and Disease
  5. Glucocorticoids inhibit the cytokine-induced proliferation of mast cells, the high affinity IgE receptor-mediated expression of TNF-alpha, and the IL-10-induced expression of chymases
    Kari K. Eklund, Donald E. Humphries, Z Xia, N Ghildyal, DS Friend, V Gross, Richard L Stevens · 1997 · The Journal of Immunology
  6. Alterations in interleukin-4 and antibody production following pheromone exposure: Role of glucocorticoids
    Jan A. Moynihan, Jonathan D. Karp, Nicholas Cohen · 1994 · Journal of Neuroimmunology
  7. Glucocorticoids: action and new therapeutic insights in rheumatoid arthritis
    John Kirwan, Lynsey L. Power · 2007 · Current Opinion in Rheumatology
  8. Nano-Drugs Based on Nano Sterically Stabilized Liposomes for the Treatment of Inflammatory Neurodegenerative Diseases
    Keren Turjeman, Yaelle Bavli, Pablo Kizelsztein, Yaelle Schilt, Nahum Allon, Tamar Blumenfeld‐Katzir, Efrat Sasson, Uri Raviv, Haim Ovadia, Yechezkel Barenholz · 2015 · PLoS ONE
  9. Inhaled Glucocorticoid Therapy of Childhood Asthma Is Associated With Reduced Peripheral Blood T Cell Activation and ‘Th2-Type’ Cytokine mRNA Expression
    Vasso Gemou-Engesæth, Andy Bush, A. Barry Kay · 1997 · PEDIATRICS
  10. Pain management of the cancer patient
    Stephan Alexander Schug, Chandani Chandrasena · 2014 · Expert Opinion on Pharmacotherapy
  11. Molecular Characterization of Circulating Plasma Cells in Patients with Active Systemic Lupus Erythematosus
    Patricia Lugar, Cassandra Love, Amrie C. Grammer · 2012 · PLoS ONE
  12. Glucocorticoid action and novel mechanisms of steroid resistance: role of glucocorticoid receptor-interacting proteins for glucocorticoid responsiveness
    A-C Wikström · 2003 · Journal of Endocrinology
  13. A Study of Prednisone Therapy in Chronic Lymphocytic Leukemia
    RICHARD K. SHAW, Dane R. Boggs, HAROLD R. SILBERMAN · 1961 · Blood
  14. The interplay between neuroendocrine activity and psychological stress-induced exacerbation of allergic asthma
    Tomomitsu Miyasaka, Kaori Dobashi-Okuyama, Tomoko Takahashi, Motoaki Takayanagi, Isao Ohno · 2017 · Allergology International
  15. Suppression of B-cell development genes is key to glucocorticoid efficacy in treatment of acute lymphoblastic leukemia
    Karina Kruth, Mimi Fang, Dawne N. Shelton, Ossama Abu‐Halawa, Ryan W. Mahling, Hongxing Yang, Jonathan S. Weissman, Mignon L. Loh, Markus Müschen, Sarah Kathleen Tasian et al. · 2017 · Blood
  16. Glucocorticoids Induce a TH2 Response In Vitro
    Francisco Ramírez · 1997 · Journal of Immunology Research
  17. Recruitment of CD1a+ Langerhans cells to the nasal mucosa in seasonal allergic rhinitis and effects of topical corticosteroid therapy
    Stephen J. Till, Mikila R. Jacobson, F. O'Brien, Stephen R. Durham, Alex KleinJan, Wytske Johanna Fokkens, Sigurður Júlíusson, Olle Lowhagen · 2001 · Allergy
  18. Dexamethasone inhibits maturation, cytokine production and FcεRI expression of human cord blood‐derived mast cells
    S. J. Smith, Adrian Martin Piliponsky, F. Rosenhead, Uriel Elchalal, Arnon Nagler, Francesca Levi‐Schaffer · 2002 · Clinical & Experimental Allergy
  19. Airway Epithelial Cells Are Crucial Targets of Glucocorticoids in a Mouse Model of Allergic Asthma
    Carina Klaßen, Anna Karabinskaya, Lien Dejager, Sabine Vettorazzi, Justine Van Moorleghem, Fred Lühder, Sebastiaan H. Meijsing, Jan Peter Tuckermann, Hanibal Bohnenberger, Claude Libert et al. · 2017 · The Journal of Immunology
  20. Glucocorticosteroids in Nano-Sterically Stabilized Liposomes Are Efficacious for Elimination of the Acute Symptoms of Experimental Cerebral Malaria
    Judith H. Waknine-Grinberg, Simcha Even‐Chen, Jasmine Avichzer, Keren Turjeman, Annael Bentura-Marciano, Richard Kingston Haynes, Lola Weiss, Nahum Allon, Haim Ovadia, Jacob Golenser et al. · 2013 · PLoS ONE
  21. Duration of Systemic Corticosteroids in the Treatment of Asthma Exacerbation. A Randomized Study.
    Tsuyoshi Hasegawa, Kyosuke Ishihara, Shunji Takakura, Hiroshi Fujii, Takashi Nishimura, Miki Okazaki, Nobuyuki Katakami, Bunichi Umeda · 2000 · Internal Medicine
  22. Fifty Years of Experience with Cortisone Therapy in the Study and Treatment of Rheumatoid Arthritis
    Gunther Neeck · 2002 · Annals of the New York Academy of Sciences
  23. GRAND-4: the German retrospective analysis of long-term persistence in women with osteoporosis treated with bisphosphonates or denosumab
    Peyman Hadji, Ioannis Kyvernitakis, P. H. Kann et al. · 2016 · Osteoporosis International
  24. An in vitro comparison of commonly used topical glucocorticoid preparations
    Cristiana Stellato, Jun Atsuta, Carol Bickel, Robert P. Schleimer · 1999 · Journal of Allergy and Clinical Immunology
  25. Glucocorticoids for Management of Polymyalgia Rheumatica and Giant Cell Arteritis
    Eric L. Matteson, Frank Buttgereit, Christian Dejaco, Bhaskar Dasgupta · 2015 · Rheumatic Disease Clinics of North America
  26. Herpes Zoster-Attributable Resource Utilization and Cost Burden in Patients With Solid Organ Transplant
    Liisa A. Palmer, Ronald R. White, Barbara H. Johnson · 2014 · Transplantation
  27. Glucocorticosteroids Inhibit Leukotriene Production
    I. Caroline Crocker, Chang Yi Zhou, Againdra K. Bewtra · 1997 · Annals of Allergy Asthma & Immunology
  28. The gene encoding interleukin-13: a susceptibility locus for asthma and related traits
    Marsha A. Wills-Karp · 2000 · Respiratory Research
  29. Prospective, placebo-controlled trial of 5 vs 10 days of oral prednisolone in acute adult asthma
    Andrew M. Jones, Mohammed Munavvar, Andy Vail · 2002 · Respiratory Medicine
  30. Integrating Systemic Information at the Molecular Level
    Damián Refojo, Ana C. Liberman, Damiana Giacomini, Alberto Carbia Nagashima, Mariana Graciarena, Carlos Echenique, Marcelo Páez-Pereda, Günter Karl Stalla, FLORIAN HOLSBOER, EDUARDO S. ARZT · 2003 · Annals of the New York Academy of Sciences
  31. The risk of asthma exacerbation after reducing inhaled corticosteroids: a systematic review and meta‐analysis of randomized controlled trials
    John B. Hagan, Shefali Anil Samant, Gerald W. Volcheck · 2014 · Allergy
  32. Approaches to stepping up and stepping down care in asthmatic patients
    Alex Thomas, Robert F. Lemanske, Daniel J. Jackson · 2011 · Journal of Allergy and Clinical Immunology
  33. P-Glycoprotein and Drug Resistance in Systemic Autoimmune Diseases
    Andrea Picchianti Diamanti, Maria Manuela Rosado, Marco Scarsella · 2014 · International Journal of Molecular Sciences
  34. Glucocorticoids inhibit IL-4 and mitogen-induced IL-4Rα chain expression by different posttranscriptional mechanisms☆☆☆★★★♢
    Lourdes Mozo, Abel Gayo, Ana Suárez, Dolores Rivas, José Zamorano, Carmen Gutiérrez · 1998 · Journal of Allergy and Clinical Immunology
  35. Prednisone treatment inhibits the differentiation of B lymphocytes into plasma cells in MRL/MpSlac-lpr mice
    Shang-Xue Yan, Xiao-Mei Deng, Qing-Tong Wang, Xiao-Jing Sun, Wei Wei · 2015 · Acta Pharmacologica Sinica
  36. New insights into the role and mechanism of macrophage migration inhibitory factor in steroid-resistant patients with systemic lupus erythematosus
    Fang-Fang Wang, Lian Zhu, Yu-Qiong Zou, Hui Wen Zheng, Alisa Wilson, Chengde Yang, Nan Shen, Daniel J. Wallace, Michael H. Weisman, Shun‐le Chen et al. · 2012 · Arthritis Research & Therapy
  37. Glucocorticoid-targeted therapies for the treatment of rheumatoid arthritis
    Cindy Strehl, Marlies C. van der Goes, J. W. J. Bijlsma, Johannes W. G. Jacobs, Frank Buttgereit · 2017 · Expert Opinion on Investigational Drugs
  38. Glucocorticoid-induced leucine zipper (GILZ) inhibits B cell activation in systemic lupus erythematosus
    Sarah A. Jones, Andrew E. J. Toh, Dragana Odobasic, Marie-Anne Virginie Oudin, Qiang Cheng, Jacinta P. W. Lee, Stefan J. White, Brendan E. Russ, Simona Infantino, Amanda Light et al. · 2015 · Annals of the Rheumatic Diseases
  39. Association of macrophage migration inhibitory factor −173C allele polymorphism with steroid resistance in children with nephrotic syndrome
    Afig Berdeli, Sevgı Mır, Neşe Özkayın · 2005 · Pediatric Nephrology
  40. Glucocorticoids Modulate Th1 and Th2 Responses in Asthmatic Mouse Models by Inhibition of Notch1 Signaling
    Chengping Hu, Zhifang Li, Juntao Feng, Yongjun Tang, Ling Qin, Xinyue Hu, Yan Zhang, Ruoxi He · 2018 · International Archives of Allergy and Immunology
  41. The phase-shift mutation in the glucocorticoid receptor gene: potential etiologic significance of neuroendocrine mechanisms in lupus nephritis
    Tang Jiang, Shuangxin Liu, Min Tan, Fengxian Huang, Yuling Sun, Xiouqing Dong, Weiming Guan, Linghong Huang, Feiyu Zhou · 2001 · Clinica Chimica Acta
  42. Pathogenesis of giant-cell arteritis: how targeted therapies are influencing our understanding of the mechanisms involved
    Nekane Terrades-García, Maria Cinta Cid · 2017 · Lara D. Veeken
  43. Downregulation of immunological mediators in 2,4-dinitrofluorobenzene-induced atopic dermatitis-like skin lesions by hydrocortisone-loaded chitosan nanoparticles
    Haliza Katas, Zahid Hussain, Mohd Cairul Iqbal Mohd Amin, Endang Kumolosasi, Shariza Sahudin · 2014 · International Journal of Nanomedicine
  44. Reverse plasticity: TGF‐β and IL‐6 induce Th1‐to‐Th17‐cell transdifferentiation in the gut
    Jens Geginat, Moira Paroni, Ilko Kastirr, Paola Larghi, Massimiliano Pagani, Sergio Abrignani · 2016 · European Journal of Immunology
  45. Allergische Krankheiten in Deutschland
    E. Hermann-Kunz · 2000 · Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz
  46. Allergische Krankheiten in DeutschlandErgebnisse einer repräsentativen Studie
    E. Hermann-Kunz · 2000 · Publication server of the Robert Koch Institute (Robert Kock Institute)
  47. Effect of Glucocorticoid Therapy on Glucocorticoid Receptors in Children with Autoimmune Diseases
    Judit Andreae, Robert Tripmacher, Renita Weltrich · 2001 · Pediatric Research
  48. Erg and AP-1 as determinants of glucocorticoid response in acute lymphoblastic leukemia
    D W-C Chen, Vaskar Saha, J-Z Liu, Jean‐Marc Schwartz, Marija Krstic–Demonacos · 2012 · Oncogene
  49. The effect of steroid on myeloid leukemic cells: The potential of short-course high-dose methylprednisolone treatment in inducing differentiation, apoptosis and in stimulating myelopoiesis
    Gönül Hiçsönmez · 2005 · Leukemia Research
  50. Involvement of the Glucocorticoid Receptor in the Pathogenesis of Rheumatoid Arthritis
    Gunther Neeck, Andreas Klüter, Helmut Dotzlaw, Martin Eggert · 2002 · Annals of the New York Academy of Sciences
  51. Glucocorticoid receptor in patients with lupus nephritis: relationship between receptor levels in mononuclear leukocytes and effect of glucocorticoid therapy.
    Hirotoshi Tanaka, Hideto Akama, Y Ichikawa, Isao Makino, M Homma · 1992 · PubMed
  52. Definition and Diagnosis of Intrinsic Versus Extrinsic Atopic Dermatitis
    Brunello Wüthrich, Peter Schmid‐Grendelmeier · 2002 · CRC Press eBooks
  53. Reviewing the Pathophysiology Behind the Advances in the Management of Giant Cell Arteritis
    Alia Z. Al-Mousawi, Sam Gurney, Alice R. Lorenzi · 2019 · Ophthalmology and Therapy
  54. Persistent expression and function of P-glycoprotein on peripheral blood lymphocytes identifies corticosteroid resistance in patients with systemic lupus erythematosus
    Amit Kansal, Deepak Tripathi, Mohit K. Rai · 2015 · Clinical Rheumatology
  55. Up-regulation of transcription factor Blimp1 in systemic lupus erythematosus
    Jie Denny Luo, Xiaochang Niu, Hongchun Liu, Mingxu Zhang, Ming Chen, Shaoli Deng · 2013 · Molecular Immunology
  56. A liposomal steroid nano-drug for treating systemic lupus erythematosus
    Eli Moallem, Erez Koren, Rina Ulmansky, Galina Pizov, M Barlev, Yechezekel Barenholz, Yaakov Naparstek · 2016 · Lupus
  57. The progress and current status of immunotherapy in acute myeloid leukemia
    Dan Yang, Xiuqun Zhang, Xuezhong Zhang · 2017 · Annals of Hematology
  58. Wirkmechanismen nasaler Glukokortikosteroide in der Therapie der allergischen Rhinitis
    L. Klimek, Petra Högger, Oliver Pfaar · 2012 · HNO
  59. Elevated Ratio of Th17 Cell-Derived Th1 Cells (CD161 + Th1 Cells) to CD161 + Th17 Cells in Peripheral Blood of Early-Onset Rheumatoid Arthritis Patients
    Shigeru Kotake, Yuki Nanke, Toru Yago, Manabu Kawamoto, Tsuyoshi Kobashigawa, Hisashi Yamanaka · 2016 · BioMed Research International
  60. T regulatory cell phenotypes in peripheral blood and bronchoalveolar lavage from non‐asthmatic and asthmatic subjects
    Adrian J. Baatjes, Steven G. Smith, RICK M. WATSON, K.J. Howie, Desmond M. Murphy, Mark Larché, Judah A. Denburg, Mark D. Inman, Paul M. O’Byrne · 2015 · Clinical & Experimental Allergy
  61. [ 18 ]F FDG PET/CT imaging to monitor the therapeutic effect of liposome-encapsulated prednisolone in experimental rheumatoid arthritis
    Tessa van der Geest, Josbert M. Metselaar, Danny Gerrits · 2015 · Journal of Controlled Release
  62. Down regulation of glucocorticoid receptors in early-diagnosed rheumatoid arthritis.
    Amalia A. van Everdingen, Huisman Am, M. J. G. Wenting, DR Siewertsz van Reesema, Johannes W. G. Jacobs, J. W. J. Bijlsma · 2002 · PubMed
  63. Molecular mechanisms of glucocorticoid resistance in systemic lupus erythematosus: A review
    Hongyan Gao, Qin Wang, Xiaowen Yu, Jinkun Liu, Shutong Bai, Jing Chun Feng, Bin Wu · 2018 · Life Sciences
  64. Glucocorticoid receptors in systemic lupus erythematosus.
    Dafna D. Gladman, Murray B. Urowitz, F. Doris, Krzysztof Cezary Lewandowski, K. A. B. Anhorn · 1991 · PubMed
  65. Serum levels of P-glycoprotein and persistence of disease activity despite treatment in patients with systemic lupus erythematosus
    Edsaúl Emilio Pérez-Guerrero, Jorge Iván Gámez-Nava, José Francisco Muñóz-Valle et al. · 2017 · Clinical and Experimental Medicine
  66. Glucocorticoids promote intrinsic human TH17 differentiation
    Juliana de Castro Kroner, Kristin Knoke, David M. Kofler, Julia Steiger, Mario Fabri · 2018 · Journal of Allergy and Clinical Immunology
  67. Cytokine signaling/transcription factor cross-talk in T cell activation and Th1-Th2 differentiation.
    Ana C. Liberman, Damián Refojo, EDUARDO S. ARZT · 2003 · PubMed
  68. Precision medicine in the treatment stratification of AML patients: challenges and progress
    Ines Lohse, Kurt Statz-Geary, Shaun P. Brothers, Claes Wahlestedt · 2018 · Oncotarget
  69. Negative Relationship Between Expression of Glucocorticoid Receptor α and Disease Activity: Glucocorticoid Treatment of Patients with Systemic Lupus Erythematosus
    Li Xiu, FENG-SHAN ZHANG, Jihui Zhang, Jingyuan Wang · 2009 · The Journal of Rheumatology
  70. Hydrocortisone selectively inhibits IgE-dependent arachidonic acid release from rat peritoneal mast cells
    Ann S. Heiman, Fulton T. Crews · 1984 · Prostaglandins
  71. Advances in chronic lymphocytic leukemia pharmacotherapy
    Lorena Caixeta Gomes, Aline Lúcia Menezes Ferrão, Fernanda Cristina Gontijo Evangelista, Tâmara Dauare de Almeida, Rayson Carvalho Barbosa, María das Graças Carvalho Ferriani, Adriano de Paula Sabino · 2017 · Biomedicine & Pharmacotherapy
  72. Arthritis and endogenous glucocorticoids: the emerging role of the 11β-HSD enzymes
    Frank Buttgereit, Hong Zhou, Markus J. Seibel · 2008 · Annals of the Rheumatic Diseases
  73. Glucocorticoid‐Induced Proliferation in Untreated Pediatric Acute Myeloid Leukemic Blasts
    K. Klein, E. Haarman, V. de Haas, C. Zwaan, U. Creutzig, G. Kaspers · 2016 · Pediatric Blood & Cancer
  74. Steroid resistance in leukemia
    Darshan Shah · 2013 · World Journal of Experimental Medicine
  75. Tyrosine Kinase Inhibitor Treatment for Newly Diagnosed Chronic Myeloid Leukemia
    Jerald P. Radich, Michael J. Mauro · 2017 · Hematology/Oncology Clinics of North America
  76. Betamethasone, but Not Tacrolimus, Suppresses the Development of Th2 Cells Mediated by Langerhans Cell-Like Dendritic Cells
    Katsuhiko Matsui, Saki Tamai, Reiko Ikeda · 2016 · Biological and Pharmaceutical Bulletin
  77. The ibrutinib B-cell proliferation inhibition is potentiated in vitro by dexamethasone: Application to chronic lymphocytic leukemia
    Delphine Manzoni, Régine Catallo, Amel Chebel, Lucile Baseggio, Anne‐Sophie Michallet, Olivier Roualdes, Jean‐Pierre Magaud, Gilles Salles, Martine Ffrench · 2016 · Leukemia Research
  78. Rituximab in moderate to severe non-renal systemic lupus erythematosus: a reanalysis of the EXPLORER study
    Marc Scherlinger, Claire Carcaud, Marie‐Elise Truchetet · 2019 · Annals of the Rheumatic Diseases
  79. Differential Cytokine Profiles upon Comparing Selective versus Classic Glucocorticoid Receptor Modulation in Human Peripheral Blood Mononuclear Cells and Inferior Turbinate Tissue
    Ilse M. E. Beck, Koen Van Crombruggen, Gabriële Holtappels, François Daubeuf, Nelly Frossard, Claus Bachert, Karolien De Bosscher · 2015 · PLoS ONE
  80. The intelligent use of systemic glucocorticoids in rheumatoid arthritis
    Cecilia Mercieca, John Kirwan · 2013 · Expert Review of Clinical Immunology
  81. Wirkmechanismen nasaler Glukokortikosteroide in der Therapie der allergischen Rhinitis
    L. von Bernus, Petra Högger, Oliver Pfaar · 2012 · HNO